Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.42 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 6/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.34 |
| ▸ | FEN1 | P39748 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | EGLN2 | Q96KS0 | 3/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19903442 | 0.89 | TRPV4 (0.47) | CYP11B1CYP11B2TRPV4ARALOX5AP | |
| SCHEMBL19903598 | 0.78 | CYP11B1 (0.44) | CYP11B1CYP11B2TRPV4ARALOX5AP | |
| SCHEMBL19912364 | 0.75 | TRPV4 (0.40) | CYP11B1CYP11B2TRPV4ARNOTUM | |
| SCHEMBL18882662 | 0.73 | AR (0.40) | CYP11B1CYP11B2TRPV4AR | |
| SCHEMBL22822524 | 0.73 | RXRA (0.44) | CYP11B1CYP11B2TRPV4ARALOX5AP | |
| SCHEMBL19912365 | 0.73 | NOTUM (0.40) | CYP11B1CYP11B2ARNOTUMEGLN2 | |
| SCHEMBL14134208 | 0.72 | AR (0.41) | ARNOTUMCTSSCTSK | |
| SCHEMBL25658474 | 0.71 | ALOX5AP (0.50) | CYP11B1CYP11B2TRPV4ARALOX5AP | |
| SCHEMBL20444106 | 0.71 | TRPV4 (0.60) | CYP11B1CYP11B2TRPV4ESR1ESR2 | |
| SCHEMBL14133906 | 0.71 | RXRA (0.36) | ARNOTUMCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | CYP11B1 823/4885CYP11B2 550/4885TRPV4 1280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.